![Marco Jaspers](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Ursprung des Netzwerks ersten Grades von Marco Jaspers
Einheit | Art der Einheit | Industrie | |
---|---|---|---|
BioConnection BV
![]() BioConnection BV BiotechnologyHealth Technology BioConnection BV manufactures and develops injectable pharmaceutical products. Its services include fill & finish, freeze drying, clinical trial material services, project management and consultancy services. The company was founded in 2005 and is headquartered in Oss, the Netherlands.
4
| Holding Company | Biotechnology | 4 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Marco Jaspers
Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
---|---|---|---|
University of Amsterdam | College/University | Doctorate Degree Doctorate Degree | |
Morphochem AG
![]() Morphochem AG Miscellaneous Commercial ServicesCommercial Services Morphochem AG discovers and develops drugs. It focuses on finding therapeutic agents to treat cancer, anti-infectives, inflammation, metabolic disorders and infectious diseases, with particular emphasis on enzyme inhibitors. The company has developed an integrated chemical genomics drug discovery engine that it is applying in third party research programs and for building its own fully owned pipeline. Morphochem is headquartered in Munich, Germany. | Miscellaneous Commercial Services | Chief Executive Officer | |
PHARMING GROUP N.V. | Pharmaceuticals: Major | Chief Executive Officer | |
Sylus Pharmaceuticals Ltd. | Director/Board Member | ||
Ashridge Business School | College/University | Masters Business Admin | |
Midatech Ltd.
![]() Midatech Ltd. BiotechnologyHealth Technology Midatech Ltd. engages in research and experimental development on biotechnology services. The company is headquartered in Abingdon, the United Kingdom. | Biotechnology | Director/Board Member | |
BIODEXA PHARMACEUTICALS PLC | Pharmaceuticals: Major | Director/Board Member | |
Pharming Intellectual Property BV
![]() Pharming Intellectual Property BV Trucks/Construction/Farm MachineryProducer Manufacturing Part of Pharming Group NV, Pharming Intellectual Property BV manufactures milking equipment. The company is based in Leiden, Netherlands. The CEO of the Dutch company is Sijmen de Vries. | Trucks/Construction/Farm Machinery | Chief Executive Officer | |
Organon NV
![]() Organon NV Pharmaceuticals: MajorHealth Technology N.V. Organon engages in the development, manufacture, and sale of prescription medicines. It offers products for cardiovascular diseases, fertility, gynecology, anesthesia, respiratory, consumer health care, neuroscience as well as immunology, animal health, and oncology. Its products include mometasone furoate inhalation powder, moxifloxacin, pegylated liposomal doxorubicin HCI, desogestrel, desloratadine, sun care, flu medicine, foot care, follitropin beta, formoterol fumarate inhalation powder, hormone therapy, and canine vaccines. The company was founded in 1923 and is headquartered in Oss, the Netherlands. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Octoplus AB
![]() Octoplus AB Information Technology ServicesTechnology Services Part of CGI, Inc., Octoplus AB provides Internet consulting services. The company is based in Helsingborg, Sweden. Octoplus was acquired by WM-data AB on March 09, 2000. | Information Technology Services | Corporate Officer/Principal | |
Delft University of Technology | College/University | Doctorate Degree | |
Sandoz Pharmaceuticals Corp. | Corporate Officer/Principal | ||
DSM Biologics Holding, Inc.
![]() DSM Biologics Holding, Inc. BiotechnologyHealth Technology Part of DSM-Firmenich AG, DSM Biologics Holding, Inc. is a Canadian company that manufactures biological and pharmaceutical products. The private company is based in Montréal, Canada. The company was founded by Jos van Weperen. DSM Biologics Holding was acquired by DSM Pharmaceuticals, Inc., a subsidiary of DSM-Firmenich AG from Province of Québec on July 13, 2005. | Biotechnology | Corporate Officer/Principal | |
Rhein Biotech GmbH
![]() Rhein Biotech GmbH Medical SpecialtiesHealth Technology Rhein Biotech GmbH develops, manufactures and markets biopharmaceutical products and technologies. Its products treat and prevent infectious diseases, allergies, cancer, and chronic inflammatory diseases. The company was founded by Cornelis P. Hollenberg and Zbigniew Janowicz in 1985 and is located in Dusseldorf, Germany. | Medical Specialties | Corporate Officer/Principal | |
PIERREL S.P.A. | Pharmaceuticals: Other | Corporate Officer/Principal |
Statistik
International
Niederlande | 6 |
Vereinigtes Königreich | 5 |
Deutschland | 3 |
Schweiz | 2 |
Schweden | 2 |
Sektoral
Health Technology | 9 |
Consumer Services | 4 |
Commercial Services | 2 |
Producer Manufacturing | 2 |
Technology Services | 2 |
Operativ
Corporate Officer/Principal | 8 |
Chief Executive Officer | 5 |
Director/Board Member | 4 |
Doctorate Degree | 3 |
Director of Finance/CFO | 1 |
Am stärksten vernetzte Beziehungen
Insiders | |
---|---|
Sijmen de Vries | 10 |
Sjaak Stevense | 6 |
Alexander Willemse | 4 |
Rob van Rooij | 1 |
- Börse
- Insiders
- Marco Jaspers
- Unternehmensverbindungen